West Pharma (WST) Tops Q2 EPS by 17c, Revenues Beat; Raises FY19 EPS/Revenue Guidance
Tweet Send to a Friend
West Pharma (NYSE: WST) reported Q2 EPS of $0.89, $0.17 better than the analyst estimate of $0.72. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE